Monument, Inc.

Monument, Inc. specializes in telehealth services, offering accessible video appointments with licensed healthcare professionals. Their user-friendly platform facilitates mental and physical health care, ensuring convenience and affordability for users across the United States. Monument, Inc.

was founded in 2019 and is based in New York, US. The company specializes in telehealth, providing remote access to therapists and doctors. The founders include Amit Klein, Irene Zhou, and Michael Russell, with John Ference serving as the CEO. Monument has raised a total of USD 10.

3 mn, with the latest funding round being a Series A led by VMG Partners on January 6, 2021. This funding is part of the company's growth strategy to enhance their service offerings. Monument, Inc. primarily provides telehealth services through video appointments with licensed therapists and doctors, costing USD 25 per session for insured individuals.

Their platform enables users to schedule appointments, manage prescriptions, and build long-term relationships with healthcare professionals. They cater to a wide range of healthcare needs, including both physical and mental health, making professional healthcare accessible to a diverse audience throughout the United States. The company's revenue is generated primarily from video appointment services, where clients pay USD 25 per session with insurance coverage. This direct transaction model allows individuals to access professional healthcare without high costs, promoting both one-time and recurring appointments.

The firm also ensures transparency by offering refunds if out-of-pocket expenses are lower than their stated fee, further encouraging user retention and commitment. In January 2021, Monument, Inc. secured USD 10. 3 mn in Series A funding led by VMG Partners, which will be utilized to expand into new markets and enhance their service offerings.

The company plans to introduce upcoming products designed for improved user experience and to broaden its reach across various regions in the United States by targeting specific markets by the end of 2023.